Magnolia Medical Technologies
Seattle, US · Founded 2011 · Washington corporation · 82 employees on LinkedIn · 5 known investors
Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.
Founders & leadership
Magnolia Medical Technologies was founded in 2011 by Richard G Patton, Gregory J Bullington, and Richard Patton.
RG
Richard G PattonCo-founder
GJ
Gregory J BullingtonCo-founder
RP
Richard PattonCo-founder
Board
PM
Paul MeisterBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$91.6M disclosed across 6 rounds · 2015–2022
▶$43.4MraisedJan 2022 · 18 investors · Other Health CareRule 506(b)
▶$43.4MraisedJan 2022 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul EneverDirector
- Ronald LowyDirector
- Kathryn BealDirector
- Ovid AmadiDirector
- Paul MeisterDirector
- Gregory J BullingtonExecutive Officer, Director
- Marc-Andre MarcotteDirector
- Randy ScottExecutive Officer, Director
- Offering amount
- $46.4M
- Amount sold
- $43.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$19.6MraisedJan 2019 · 31 investors · Other Health CareRule 506(b)
▶$19.6MraisedJan 2019 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JOSH BALTZELLDirector
- PAUL MEISTERDirector
- RANDY SCOTTExecutive Officer, Director
- GREGORY J BULLINGTONExecutive Officer, Director
- RICHARD G PATTONExecutive Officer, Director
- PAUL ENEVERDirector
- Offering amount
- $20M
- Amount sold
- $19.6M
- First sale
- Dec 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$21MraisedMar 2017 · 33 investors · Other Health CareRule 506(b)
▶$21MraisedMar 2017 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul M MeisterDirector
- Paul EneverDirector
- Josh BaltzellDirector
- Richard G PattonExecutive Officer, Director
- Gregory J BullingtonExecutive Officer, Director
- Garheng KongDirector
- Offering amount
- $21M
- Amount sold
- $21M
- First sale
- Jun 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$70KraisedJun 2016 · 1 investors · Other TechnologyRule 506(b)
▶$70KraisedJun 2016 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard G PattonExecutive Officer, Director
- Paul M MeisterDirector
- Gregory J BullingtonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $70K
- First sale
- May 2016
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
▶$1.4MraisedMar 2016 · 6 investors · Other TechnologyRule 506(b)
▶$1.4MraisedMar 2016 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- PAUL M MEISTERDirector
- GREGORY J BULLINGTONExecutive Officer, Director
- RICHARD G PATTONExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Feb 2016
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
▶$6.2MraisedJun 2015 · 9 investors · Other TechnologyRule 506(b)
▶$6.2MraisedJun 2015 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul MeisterDirector
- Richard G PattonDirector
- Gregory J BullingtonExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $6.2M
- First sale
- May 2015
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Magnolia Medical Technologies went on to found or lead other companies.
Competitors · 3
by search overlapLabcorp309 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Oup163 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
BYJU'S136 shared keywordsBYJU'S offers online learning programs, video lessons, and a personalized learning app for students in India, including tutoring and exam-preparation programs for competitive tests such as JEE and NEET.
Companies competing with Magnolia Medical Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Magnolia Medical Technologies do?
- Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.
- Who founded Magnolia Medical Technologies?
- Magnolia Medical Technologies was founded by Richard G Patton, Gregory J Bullington, Richard Patton in 2011.
- Who are Magnolia Medical Technologies's investors?
- Magnolia Medical Technologies's investors include Evidity Health Capital, Lauder Partners, Rhapsody Venture Partners, Vivo Capital, HealthQuest Capital.
- How much funding has Magnolia Medical Technologies raised?
- Magnolia Medical Technologies has disclosed $91.6M raised across 6 rounds.
- Where is Magnolia Medical Technologies headquartered?
- Magnolia Medical Technologies is headquartered in Seattle, US.